Your browser doesn't support javascript.
loading
TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity.
Gatt, Moshe E; Takada, Kohichi; Mani, Mala; Lerner, Mikael; Pick, Marjorie; Hideshima, Teru; Carrasco, Daniel E; Protopopov, Alexei; Ivanova, Elena; Sangfelt, Olle; Grandér, Dan; Barlogie, Bart; Shaughnessy, John D; Anderson, Kenneth C; Carrasco, Daniel R.
Affiliation
  • Gatt ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Br J Haematol ; 162(2): 210-20, 2013 Jul.
Article in En | MEDLINE | ID: mdl-23647456

Full text: 1 Database: MEDLINE Main subject: NF-kappa B / Tumor Suppressor Proteins / Proteasome Endopeptidase Complex / DNA-Binding Proteins / Multiple Myeloma Limits: Humans Language: En Journal: Br J Haematol Year: 2013 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: NF-kappa B / Tumor Suppressor Proteins / Proteasome Endopeptidase Complex / DNA-Binding Proteins / Multiple Myeloma Limits: Humans Language: En Journal: Br J Haematol Year: 2013 Type: Article Affiliation country: United States